RS438568 Unknown gene
Upload your DNA to see your genotype for this variant.
GWAS Studies (20)
| Trait | Risk Allele | OR / Beta | P-value | Study |
|---|---|---|---|---|
| Ceramide (d17:1/22:0) levels | G | OR: 0.38 | 6E-67 | PubMed |
| Plasma sphingomyelin (d18:1/25:0, d19:0/24:1, d20:1/23:0, d19:1/24:0)* levels in chronic kidney disease | G | OR: 0.22 | 1E-62 | PubMed |
| Ceramide (d17:1/22:0) levels | G | OR: 0.35 | 6E-57 | PubMed |
| Sphingomyelin (d16:1/19:0) levels | G | OR: 0.32 | 2E-45 | PubMed |
| Sphingomyelin (d18:1/19:0, d19:1/18:0) levels | G | OR: 0.2 | 3E-42 | PubMed |
| Ceramide (d17:1/20:0) levels | G | OR: 0.28 | 6E-35 | PubMed |
| Monohexosylceramide (d16:1/20:0) levels | G | OR: 0.26 | 1E-31 | PubMed |
| Ceramide (d17:1/20:0) levels | G | OR: 0.25 | 6E-30 | PubMed |
| Plasma ceramide (d16:1/24:1, d18:1/22:1)* levels in chronic kidney disease | G | OR: 0.21 | 6E-30 | PubMed |
| Monohexosylceramide (d16:1/22:0) levels | G | OR: 0.26 | 9E-30 | PubMed |
| Ceramide (d40:2) levels | A | OR: 0.23 | 4E-29 | PubMed |
| Total Ceramide [S19] levels | — | OR: 0.48 | 4E-29 | PubMed |
| Ceramide [N(24)S(19)] levels | — | OR: 0.47 | 1E-27 | PubMed |
| Dihydroceramide (d18:0/24:0) levels | G | OR: 0.24 | 3E-27 | PubMed |
| Cholesteryl Esters to Total Lipids in IDL percentage | G | β: 0.02 | 2E-26 | PubMed |
| Sphingomyelin (d18:1/21:0, d17:1/22:0, d16:1/23:0) levels | G | OR: 0.16 | 3E-26 | PubMed |
| Monohexosylceramide (d16:1/18:0) levels | G | OR: 0.24 | 7E-26 | PubMed |
| Sphingomyelin (d18:1/20:0, d16:1/22:0) levels | A | OR: 0.16 | 4E-25 | PubMed |
| Sphingomyelin (d16:1/19:0) levels | G | OR: 0.23 | 3E-24 | PubMed |
| Ceramide (d18:2/24:1) levels | G | OR: 0.22 | 4E-22 | PubMed |